TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9678311

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) levels of amyloid beta protein (Abeta42)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) levels of tau
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Classification tree analysis comparing AD and NC subjects
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: CSF markers for autopsy follow-up
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Apolipoprotein E epsilon4 allele dose
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Mini-Mental State Examination score
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 82
Study: 8036454

Group type: EXPERIMENTAL
Intervention: Famotidine (40 mg at 1830 h)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 2660379

Group type: EXPERIMENTAL
Intervention: Iopromide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iopamidol
Number of subjects: 0
Study: 30504715

Group type: EXPERIMENTAL
Intervention: Deferasirox (DFX)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Deferoxamine (DFO)
Number of subjects: 6
Study: 28885362

Group type: EXPERIMENTAL
Intervention: Bandage contact lenses (BCL) application
Number of subjects: 30

Group type: COMPARATOR
Intervention: No BCL application (control group)
Number of subjects: 30
Study: 26837817

Group type: EXPERIMENTAL
Intervention: Values clarification condition
Number of subjects: 146

Group type: COMPARATOR
Intervention: Active problem-solving control condition
Number of subjects: 146
Study: 25433353

Group type: EXPERIMENTAL
Intervention: HM+ (telemonitored by the BIOTRONIK Home Monitoring® system)
Number of subjects: 198

Group type: COMPARATOR
Intervention: HM- (standard outpatient visits)
Number of subjects: 198
Study: 22381489

Group type: COMPARATOR
Intervention: Low-intensity laser therapy (infrared radiation from a semiconductor diode laser with a wavelength of 810 nm), applied on days 0, 3, 7, and 14 in the first month, and thereafter on every 15th day until complete canine retraction was achieved.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control side (no low-intensity laser therapy applied).
Number of subjects: 20
Study: 21158963

Group type: EXPERIMENTAL
Intervention: Higher Material Style of Life (MSL) score (>12)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Intermediate MSL score (8-12)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Non-nutrient-dense foods (NNDF)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Mean frequencies of fruit and vegetables (FV) and traditional foods (TF) consumption
Number of subjects: 230
Study: 17557769

Group type: EXPERIMENTAL
Intervention: Therapeutic CPAP
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo CPAP
Number of subjects: 42
Study: 15850883

Group type: EXPERIMENTAL
Intervention: NRT + C-MIS
Number of subjects: 315

Group type: COMPARATOR
Intervention: NRT
Number of subjects: 315
Study: 12470136

Group type: EXPERIMENTAL
Intervention: Primary open-angle glaucoma (POAG)
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Primary angle-closure glaucoma (PACG)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Comparison between POAG and PACG
Number of subjects: 234
Study: 9534293

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg
Number of subjects: 89

Group type: COMPARATOR
Intervention: Hydrochlorothiazide 25 mg
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg + Hydrochlorothiazide 25 mg (L-HCTZ Group)
Number of subjects: 89
Study: 9588918

Group type: EXPERIMENTAL
Intervention: High-dose proton and photon irradiation (66.6 or 72 cobalt Gray equivalent, 1.8 CGE/day, 5 fractions/week)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: High-dose proton and photon irradiation
Number of subjects: 96
Study: 1927914

Group type: EXPERIMENTAL
Intervention: Ionic low osmolar contrast agent ioxaglate (n = 50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Nonionic low osmolar contrast media iohexol (n = 50)
Number of subjects: 100
Study: 7051984

Group type: EXPERIMENTAL
Intervention: Sulphamethoxazole
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 30676838

Group type: EXPERIMENTAL
Intervention: High-dose investigational Sabin IPV (group A)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Medium-dose investigational Sabin IPV (group B)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Low-dose investigational Sabin IPV (group C)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control Salk IPV (group D)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control Sabin IPV (group E)
Number of subjects: 600
Study: 28424269

Group type: EXPERIMENTAL
Intervention: Clopidogrel-aspirin
Number of subjects: 499

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 499
Study: 27336050

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 124

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 124
Study: 27157293

Group type: EXPERIMENTAL
Intervention: 75mg/d clopidogrel in addition to 100mg acetylsalicylic acid (ASA) for 4 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: 100mg acetylsalicylic acid (ASA) and additional placebo for 4 weeks
Number of subjects: 40
Study: 23500669

Group type: COMPARATOR
Intervention: Magnetoencephalographic Mu-modulations during observation of grasping movements in children with Asperger's syndrome.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Source localization of Mu-activity in the brain.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Correlation of brain activity with social competence.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Correlation with intellectual ability.
Number of subjects: 0
Study: 20878446

Group type: EXPERIMENTAL
Intervention: Protracted dose-dense temozolomide therapy (100 mg/m² for 21 consecutive days of a 28-day cycle)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Protracted dose-dense temozolomide therapy
Number of subjects: 25
Study: 19170737

Group type: EXPERIMENTAL
Intervention: Clobazam (high dose = target 1.0 mg/kg/day)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Clobazam (low dose = target 0.25 mg/kg/day)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Clobazam (high dose)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Clobazam (low dose)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Clobazam (both doses)
Number of subjects: 68
Study: 16442906

Group type: EXPERIMENTAL
Intervention: Risk score with 0 points (no risk factors)
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Risk score with 1 point (one risk factor)
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Risk score with 2 points (two risk factors)
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Risk score with >= 3 points (three or more risk factors)
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Risk score >= 2
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Risk score < 2
Number of subjects: 469
Study: 14767877

Group type: EXPERIMENTAL
Intervention: 1.5 g/d n3PUFA
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 800 IU/d AT
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 1.5 g n3PUFA + 800 IU/d AT
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 11411195

Group type: EXPERIMENTAL
Intervention: Bio-Hep (10 micrograms dose)
Number of subjects: 524

Group type: COMPARATOR
Intervention: Engerix-B (20 micrograms dose)
Number of subjects: 524
Study: 10064661

Group type: EXPERIMENTAL
Intervention: 5 mg zafirlukast
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 20 mg zafirlukast
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 10 mg zafirlukast
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 40 mg zafirlukast
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: All zafirlukast doses
Number of subjects: 39
Study: 7656832

Group type: EXPERIMENTAL
Intervention: Cimetidine (CMD) in combination with radiation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Radiation therapy alone
Number of subjects: 0
Study: 2713323

Group type: EXPERIMENTAL
Intervention: External pin fixation
Number of subjects: 54

Group type: COMPARATOR
Intervention: Transnasal Kirschner wire (K-wire) fixation
Number of subjects: 54
Study: 728282

Group type: EXPERIMENTAL
Intervention: Betamethasone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prednisolone
Number of subjects: 0
Study: 31378071

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Number of subjects: 4597

Group type: COMPARATOR
Intervention: Carotid artery stenting
Number of subjects: 4597
Study: 29074161

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab
Number of subjects: 362

Group type: COMPARATOR
Intervention: Intravitreal aflibercept
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Baseline VALS in the better eye
Number of subjects: 362
Study: 26527781

Group type: EXPERIMENTAL
Intervention: Mifepristone
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study: 23121470

Group type: EXPERIMENTAL
Intervention: McGrath® Series 5 videolaryngoscope
Number of subjects: 88

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 88
Study: 21816255

Group type: EXPERIMENTAL
Intervention: Pars plana vitrectomy
Number of subjects: 180

Group type: COMPARATOR
Intervention: Panretinal photocoagulation
Number of subjects: 180
Study: 19539180

Group type: EXPERIMENTAL
Intervention: Fish-oil concentrate supplementation (six 1-g soft-gel capsules daily for 6 months)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Corn-oil capsules (same protocol as fish-oil group)
Number of subjects: 87
Study: 17143946

Group type: EXPERIMENTAL
Intervention: Music played during the procedure
Number of subjects: 167

Group type: COMPARATOR
Intervention: No music played
Number of subjects: 167
Study: 15327613

Group type: EXPERIMENTAL
Intervention: Open colposuspension with sutures
Number of subjects: 240

Group type: COMPARATOR
Intervention: Laparoscopic colposuspension with mesh and staples
Number of subjects: 240
Study: 11514483

Group type: EXPERIMENTAL
Intervention: Direct coronary stenting without balloon predilatation (group I)
Number of subjects: 396

Group type: COMPARATOR
Intervention: Stenting preceded by balloon predilatation (group II)
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 396
Study: 9028091

Group type: EXPERIMENTAL
Intervention: Continuous epidural lidocaine (1% lidocaine 5ml.h‐1) during surgery combined with preoperative epidural morphine (2 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Preoperative epidural morphine (2 mg) alone
Number of subjects: 20
Study: 9480236

Group type: EXPERIMENTAL
Intervention: Healthy pregnant women
Number of subjects: 65

Group type: COMPARATOR
Intervention: Healthy non-pregnant women (control)
Number of subjects: 65
Study: 2565998

Group type: EXPERIMENTAL
Intervention: Killed hepatitis A vaccine with aluminium hydroxide as adjuvant
Number of subjects: 32

Group type: COMPARATOR
Intervention: Killed hepatitis A vaccine without aluminium hydroxide as adjuvant
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Killed hepatitis A vaccine (both groups)
Number of subjects: 32
Study: 946973

Group type: EXPERIMENTAL
Intervention: Alice influenza virus vaccine
Number of subjects: 47

Group type: COMPARATOR
Intervention: Ultraviolet inactivated vaccine
Number of subjects: 47

Group type: COMPARATOR
Intervention: 1:10 dilution of virus
Number of subjects: 47

Group type: COMPARATOR
Intervention: 1:100 dilution of virus
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (antibody-negative)
Number of subjects: 47
Study: 30811775

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT) for 12 weeks at 75% one repetition maximum
Number of subjects: 44
Study: 27862855

Group type: EXPERIMENTAL
Intervention: Oxytocin 30 IU in 500 ml normal saline
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (pure normal saline)
Number of subjects: 80
Study: 26094098

Group type: EXPERIMENTAL
Intervention: Single scrotal incision approach (89 patients, 100 testis)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Two incisions inguinal approach (80 patients, 100 testis)
Number of subjects: 200
Study: 24054187

Group type: EXPERIMENTAL
Intervention: Fospropofol
Number of subjects: 16

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 16
Study: 21789650

Group type: EXPERIMENTAL
Intervention: Z-Score SMR protocol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Z-Score IND protocol
Number of subjects: 12
Study: 19674448

Group type: EXPERIMENTAL
Intervention: Psychoeducational programme 'Beating Bipolar' via a web‐based system
Number of subjects: 100

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 100
Study: 17111019

Group type: EXPERIMENTAL
Intervention: Creatine supplementation
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 15

Group type: COMPARATOR
Intervention: Uncorrected method
Number of subjects: 15
Study: 15079129

Group type: EXPERIMENTAL
Intervention: Chemoradiation as primary management
Number of subjects: 13100

Group type: COMPARATOR
Intervention: Adjuvant postoperative chemoradiation
Number of subjects: 13100

Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiation
Number of subjects: 13100

Group type: EXPERIMENTAL
Intervention: Taxanes and irinotecan in combinations with platinum compounds and fluoropyrimidines
Number of subjects: 13100
Study: 11514813

Group type: EXPERIMENTAL
Intervention: Active SMT
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham SMT
Number of subjects: 36
Study: 9249122

Group type: EXPERIMENTAL
Intervention: PCA + high‐TAES (9‐12 mA of electrical stimulation)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: PCA + low‐TAES (4‐5 mA of electrical stimulation)
Number of subjects: 101

Group type: COMPARATOR
Intervention: PCA + sham‐TAES (no electrical stimulation)
Number of subjects: 101

Group type: COMPARATOR
Intervention: PCA only
Number of subjects: 101
Study: 8346957

Group type: EXPERIMENTAL
Intervention: dobutamine 5 micrograms/kg/min, increased to 20 micrograms/kg/min if needed
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: dopamine 5 micrograms/kg/min, increased to 12.5 micrograms/kg/min if needed
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: switch from dobutamine to dopamine
Number of subjects: 20
Study: 3730530

Group type: EXPERIMENTAL
Intervention: Administration of diethylamine chromocarbe 0.5 h before breakfast
Number of subjects: 8

Group type: COMPARATOR
Intervention: Administration of diethylamine chromocarbe at lunch
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Administration of diethylamine chromocarbe before dinner
Number of subjects: 8
Study: 31377034

Group type: EXPERIMENTAL
Intervention: CAC-DRS 3
Number of subjects: 1769

Group type: EXPERIMENTAL
Intervention: CAD-RADS 4B
Number of subjects: 1769
Study: 29716702

Group type: EXPERIMENTAL
Intervention: Ivabradine (titrated to maximum 7.5mg BD)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Standard therapy (beta blockers, ACEI, diuretics)
Number of subjects: 187
Study: 27834812

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) with weekly motivational encouragement through text messages and access to a study website
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (HIIT without motivational support)
Number of subjects: 28
Study: 24162260

Group type: EXPERIMENTAL
Intervention: Denosumab 120 mg subcutaneously monthly
Number of subjects: 1597

Group type: COMPARATOR
Intervention: Zoledronic acid 4 mg intravenously monthly
Number of subjects: 1597
Study: 22493422

Group type: EXPERIMENTAL
Intervention: Tivozanib 1.5 mg/d for 16 weeks
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Tivozanib (double-blind)
Number of subjects: 272

Group type: COMPARATOR
Intervention: Placebo (double-blind)
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Overall study population
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Treatment-related adverse events
Number of subjects: 272
Study: 20461090

Group type: EXPERIMENTAL
Intervention: Temsirolimus (25 mg intravenous weekly)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interferon-alpha (titrated to 18 mU three times weekly)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temsirolimus (15 mg intravenous weekly) plus interferon-alpha (6 mU three times weekly)
Number of subjects: 0
Study: 19087296

Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diacereine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glucosamine sulfate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Avocado/soybean unsaponifiables
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral calcitonin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Strontium ranelate
Number of subjects: 0
Study: 15960408

Group type: EXPERIMENTAL
Intervention: Size 5 ProSeal laryngeal mask airway (PLMA) in male patients
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Size 4 ProSeal laryngeal mask airway (PLMA) in female patients
Number of subjects: 60

Group type: COMPARATOR
Intervention: Size 3 ProSeal laryngeal mask airway (PLMA) in female patients
Number of subjects: 60
Study: 12610009

Group type: EXPERIMENTAL
Intervention: 0.9% alcohol beer
Number of subjects: 16

Group type: COMPARATOR
Intervention: Usual alcohol intake
Number of subjects: 16
Study: 10700794

Group type: EXPERIMENTAL
Intervention: Ondansetron 16 mg
Number of subjects: 216
Study: 8607670

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (10 g before incision)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control (250 mL placebo saline solution)
Number of subjects: 210
Study: 2016229

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Thioridazine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 7128130

Group type: EXPERIMENTAL
Intervention: TCu220C
Number of subjects: 2970

Group type: COMPARATOR
Intervention: Lippes Loop D
Number of subjects: 2970

Group type: COMPARATOR
Intervention: Copper 7
Number of subjects: 2970
Study: 30507731

Group type: EXPERIMENTAL
Intervention: With Personal Protective Equipment (WPPE, load = 12.0 kg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Without Personal Protective Equipment (NPPE, load = 5.2 kg)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: With Personal Protective Equipment (WPPE)
Number of subjects: 13
Study: 31030882

Group type: EXPERIMENTAL
Intervention: Sudden gains
Number of subjects: 44

Group type: COMPARATOR
Intervention: Gradual gains
Number of subjects: 44
Study: 28231831

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 27821162

Group type: EXPERIMENTAL
Intervention: NAVA
Number of subjects: 6

Group type: COMPARATOR
Intervention: CV
Number of subjects: 6
Study: 23817922

Group type: EXPERIMENTAL
Intervention: Performance of the action sequence
Number of subjects: 0

Group type: COMPARATOR
Intervention: Spoken repetition of instructions
Number of subjects: 0
Study: 23072844

Group type: EXPERIMENTAL
Intervention: Lignocaine hydrochloride without adrenaline (xylocaine 2%) - 2 mL
Number of subjects: 50

Group type: COMPARATOR
Intervention: Lignocaine hydrochloride with adrenaline 1:80,000 - 2 mL
Number of subjects: 50
Study: 19588529

Group type: EXPERIMENTAL
Intervention: 1,440‐nm Nd:YAG fractional laser (average fluence 3.7+/‐0.3 J/cm(2))
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 1,320/1,440‐nm multiplex Nd:YAG fractional laser (1,320‐nm average fluence 8.4+/‐0.4 J/cm(2); 1,440‐nm average fluence 2.3+/‐0.2 J/cm(2))
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both lasers
Number of subjects: 19
Study: 17969889

Group type: EXPERIMENTAL
Intervention: Shenyin Oral Liquid (SOL)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117

Group type: COMPARATOR
Intervention: Vitamin E
Number of subjects: 117
Study: 14985689

Group type: EXPERIMENTAL
Intervention: MUFA meal (40 g MUFA; 12 g SFA)
Number of subjects: 19

Group type: COMPARATOR
Intervention: SFA meal (20 g MUFA; 32 g SFA)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: MUFA meal
Number of subjects: 19

Group type: COMPARATOR
Intervention: SFA meal
Number of subjects: 19
Study: 11440963

Group type: EXPERIMENTAL
Intervention: Oltipraz given daily at 125 mg p.o.
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Oltipraz given once per week at 500 mg p.o.
Number of subjects: 201

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Cigarette smokers
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Nonsmokers
Number of subjects: 201
Study: 9730996

Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone (500 microgram twice daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 8055363

Group type: EXPERIMENTAL
Intervention: Etidronate disodium (EHDP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2659234

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Enprofylline
Number of subjects: 10

Group type: COMPARATOR
Intervention: Adenosine infusion
Number of subjects: 10
Study: 4733248

Group type: EXPERIMENTAL
Intervention: Different periods of fasting
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Fasting blood sugar
Number of subjects: 33
Study: 31089014

Group type: EXPERIMENTAL
Intervention: IV sugammadex 2 mg.kg‐1
Number of subjects: 66

Group type: COMPARATOR
Intervention: Neostigmine 0.04 mg.kg‐1 + atropine 0.01 mg.kg‐1
Number of subjects: 66
Study: 28245537

Group type: EXPERIMENTAL
Intervention: Ultrasonic lithotripter (Swiss LithoClast® Master)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Pneumatic lithotripter (Swiss LithoClast®)
Number of subjects: 29
Study: 26159135

Group type: EXPERIMENTAL
Intervention: Mobile web-based pregnancy health care educational program for 2 weeks
Number of subjects: 61

Group type: COMPARATOR
Intervention: Classroom education booklet for pregnant women
Number of subjects: 61
Study: 23021205

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention combined with daily low-glycaemic index meal replacement
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (health counselling only)
Number of subjects: 88